Skip to main content
2025 STS Annual Meeting Main banner

General Thoracic

Trainees

Early Career Surgeons

Lung Cancer Challenges in Resectable Disease: It's a Whole New World

Sunday, January 26, 2025
11:30am - 1:00pm PT
Location: 408A

    Moderator(s)

  • Kyle Mitchell, MD, MSc

    Assistant Professor
    University of Texas MD Anderson Cancer Center
    Houston, Texas, United States

    Disclosure(s): No financial relationships to disclose

  • Elliot Servais, MD

    Associate Professor, Thoracic Surgeon
    Lahey Hospital & Medical Center
    Wellesley, Massachusetts, United States

    Disclosure(s): Intuitive Surgical Inc.: Consultant (Ongoing)

Disclosure(s):
Kyle G. Mitchell, MD, MSc: No financial relationships to disclose
Elliot Servais, MD: Intuitive Surgical Inc.: Consultant (Ongoing)

Presentations:

  • 11:30am - 11:40am PT
    Synchronous Primary Stage I Non-Small Cell Lung Cancer: Trends in Management and Survival

    Presenting Author: Nikki E. Rossetti, MD, MS – Washington University School of Medicine

  • 11:40am - 11:50am PT
    Not All T4 Patients Should Be Considered Equal: NSCLC Heterogeneity and Surgical Outcome

    Presenting Author: Xun Luo, MD, MPH – West Virginia University

  • 11:50am - 12:00pm PT
    Reassessing Perioperative Risks: Impact of Neoadjuvant Therapy on Mortality in Pneumonectomy

    Presenting Author: Christina S. Boutros, DO – University Hospitals Cleveland Medical Center/ Case Western Reserve University

  • 12:00pm - 12:10pm PT
    Delayed Surgery Decreases Overall Survival in Early-Stage Non-Small Cell Lung Cancer: A Propensity Matched Cohort Analysis

    Presenting Author: Alyssa Murillo, MD, MS, MA.Ed (she/her/hers) – University of California San Francisco (UCSF)

  • 12:10pm - 12:20pm PT
    Utilization and Survival Outcomes of Surgical Resection for Clinical Stage IIIB Non-Small Cell Lung Cancer

    Presenting Author: Ryan C. Jacobs, MD, MS (he/him/his) – Northwestern University Feinberg School of Medicine

  • 12:20pm - 12:30pm PT
    Social Vulnerability Index Is Associated with Time-to-Treatment in Resectable Non-Small Cell Lung Cancer

    Presenting Author: Arsalan A. Khan, MD (he/him/his) – Rush University Medical Center

  • 12:30pm - 12:40pm PT
    Clinical Stage II Non-Small Cell Lung Cancer: Can We “Just Give Adjuvant Therapy”?

    Presenting Author: Rajika Jindani, MD, MPH (she/her/hers) – Montefiore Medical Center/ Albert Einstein College of Medicine

  • 12:40pm - 12:46pm PT
    Debate: No—Neoadjuvant Therapy for Node-Negative NSCLC

    Invited Speaker: Raja Flores, MD – Mount Sinai School of Medicine

  • 12:46pm - 12:52pm PT
    Debate: Yes—Neoadjuvant Therapy for Node-Negative NSCLC

    Invited Speaker: Nathaniel R. Evans, III, MD (he/him/his) – Thomas Jefferson University

  • 12:52pm - 1:00pm PT
    Discussion